Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256)

Sibeprenlimab (Anti-TNFSF13 / APRIL / CD256) is a fully humanized IgG2κ monoclonal antibody that targets the B-cell growth factor APRIL (TNFSF13), with the potential to treat IgA nephropathy (IgAN). MW : 145.5 KD.

Trivial name VIS649
Catalog Number A2317
CAS# 2382896-07-1
Size 1mg*5
Supplier Page http://www.selleckchem.com/products/sibeprenlimab-anti-tnfsf13-april-cd256.html